Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Petróleo Brasileiro SA (PBR) vs Sanofi SA (SNY) Price & Performance

Petróleo Brasileiro SATrade

Price performance (Past 24H)

Key statistics

Petróleo Brasileiro SA vs Sanofi SA — how do they compare? Petróleo Brasileiro SA trades at $19 (market cap $112.59B), while Sanofi SA trades at $43.89 (market cap $104.85B). The key difference: Petróleo Brasileiro SA and Sanofi SA are close in size by market cap, and Petróleo Brasileiro SA pays the higher dividend (9.51%). Which is the better fit depends on your goals.

PBRSNY
Market Cap
$112.59B$104.85B
Sector
TechnologyHealth
52-Week High
$22.03$52.34
52-Week Low
$11.54$41.33
Enterprise Value
$176.05B$121.38B
Dividend Yield
9.51%5.53%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Petróleo Brasileiro SA

Petróleo Brasileiro S.A., commonly known as Petrobras, is a state-controlled Brazilian multinational corporation in the oil and gas industry. The company is one of the world's largest producers of oil and gas, primarily operating in exploration, production, refining, and power generation. Petrobras is particularly known for its deep-sea and ultra-deep-sea exploration and production activities in the vast pre-salt offshore reserves, which are a major component of Brazil's economy.

Read more on PBR

About Sanofi SA

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Read more on SNY